The Influence of Fibrin Stabilizing Factor on the Growth of Fibroblats in vitro and Wound Healing

E Beck; F Duckert; M Ernst

doi:10.1055/s-0038-1654579

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1961; 6(03): 485-491
DOI: 10.1055/s-0038-1654579

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

The Influence of Fibrin Stabilizing Factor on the Growth of Fibroblats in vitro and Wound Healing

Authors

E Beck

¹Coagulation Laboratory (Prof. F. Koller) of the Department of Medicine (Prof. P. H. Rossier) Kantonsspital, and the Institute of Anatomy (Prof. G. Töndury), University of Zürich, Switzerland
F Duckert

¹Coagulation Laboratory (Prof. F. Koller) of the Department of Medicine (Prof. P. H. Rossier) Kantonsspital, and the Institute of Anatomy (Prof. G. Töndury), University of Zürich, Switzerland
M Ernst

¹Coagulation Laboratory (Prof. F. Koller) of the Department of Medicine (Prof. P. H. Rossier) Kantonsspital, and the Institute of Anatomy (Prof. G. Töndury), University of Zürich, Switzerland

Abstract

Summary

Congenital deficiency of Fibrin Stabilizing Factor (FSF) is the cause of both pathological haemostasis and poor wound healing. Experiments with fibroblast cultures were carried out to characterize the latter. Growth of the cultures in the patient’s plasma was quantitatively and qualitatively inferior as compared with the growth in normal control plasma, which contained FSF. Only by addition of normal plasma and purified FSF the poor cell growth was corrected. The necessity of fibrin present in the first stage of wound healing and possible modes of action of FSF in haemostasis and wound healing are discussed.

Full Text

References

References
(1) Astrup T. Blutgerinnung, Fibrinolyse und Wundheilung. Medizinische. 1959. 1972
(2) Beck E, Duckert F, Ernst M. Fibrinstabilisierender Faktor (FSF) und Wundheilung. Proc. VIII. Kongr. Europ. Ges. Haematol.. Wien: 1961. in press
(3) Duckert F, Jung E, Shmerling D. H. A hitherto undescribed congenital haemorrhagic diathesis probably due to Fibrin Stabilizing Factor deficiency. Thromb. Diath. haem. 5: 179 1960;
(4) Edwards D. C, Dunphy J. E. Wound healing. New Engl. J. Med. 259: 224 1958;
(5) Florey H. Healing. Chapter 18 in General Pathology. 2nd. Ed.. Lloyd-Luke Ltd.; London: 1958
(6) Gillman T, Penn J. Studies on repair of cutaneous wounds. Med. Proc. 2: 121 1956;
(7) Laki K, Lorand L. On the solubility of fibrin clots. Science 108: 280 1948;
(8) Loewy A. G, Edsall J. T. Studies on the formation of ureainsoluble fibrin. J. biol. Chem. 211: 829 1954;
(9) Lorand L. Proc. Intern. Congr. Soc. Haematol. Cambridge England: 1950. 407 1951
(10) Lorand L, Dickenman R. C. Assay method for the “Fibrin-Stabilizing Factor”. Proc. Soc. exp. Biol. (N. Y.) 89: 45 1955;
(11) Lorand L, Jacobsen A. Studies on the polymerization of fibrin. The role of the globulin: Fibrin-Stabilizing Factor. J. biol. Chem. 230: 421 1958;
(12) Macfarlane R. G. A boy with no fibrinogen. Lancet 1: 309 1938;
(13) Shmerling D. H, Jung E, Duckert F. Eine neue familiäre Koagulopathie infolge Mangels an fibrinstabilisierendem Faktor. Helv. paediat. Acta 15: 5 471 1960;
(14) Weiss P. Erzwingung elementarer Strukturverschiedenheiten am in vitro wachsenden Gewebe. Die Wirkung mechanischer Spannung auf Richtung und Intensität des Gewebs-wachstums und ihre Analyse. Arch. Entwickl.-Mech. org. 116: 438 1929;